Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-028744
Date:2021-04-25
Issuer: SANGAMO THERAPEUTICS, INC (SGMO)
Original Submission Date:

Reporting Person:

DURAIBABU PRATHYUSHA
C/O SANGAMO THERAPEUTICS, INC.
7000 MARINA BLVD BRISBANE, CA 94005

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-04-25 F 662 d $11.71 40,128 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents shares underlying the portion of restricted stock unit ("rsu") grant that vested on april 25, 2021 which were surrendered by the reporting person to the issuer for tax withholding, using the issuer's closing stock price on april 23, 2021 of $11.71/share, pursuant to the terms of the issuer's amended and restated 2018 equity incentive plan, as amended (the "2018 eip, as amended").
f2 includes: (a) 1,254 shares resulting from the april 25, 2021 vesting of the reporting person's april 25, 2019 rsu grant and 1,917 shares subject to such rsu grant that will vest on april 25, 2022; (b) 11,000 shares subject to the reporting person's february 25, 2020 rsu grant that will vest in two remaining annual installments of 5,499 shares and 5,501 shares on february 25, 2022 and 2023 respectively; (c) 13,750 shares subject to the reporting person's february 25, 2021 grant that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date; and (continued in footnote 3)
f3 (d) 2,000 shares subject to the reporting person's march 25, 2020 rsu grant that will vest in two remaining annual installments of 1,000 shares each shares on march 25, 2022 and 2023, respectively. the vesting of all such rsus is subject to the reporting person's continued service as defined in the 2018 eip, as amended, through such dates and subject to acceleration as defined in the 2018 eip, as amended.

Elevate your investments